Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
IOMAI
open-in-new
<h2 id="see-also">See also</h2> <ul><li><a href="/facts/Transdermal_patch/GR3Pel6S">Transdermal patch</a></li></ul> <ul><li>Frech, SA; Dupont, HL; Bourgeois, AL; McKenzie, R; Belkind-Gerson, J; Figueroa, JF; Okhuysen, PC; Guerrero, NH; Martinez-Sandoval, FG; Meléndez-Romero, JH; Jiang, ZD; Asturias, EJ; Halpern, J; Torres, OR; Hoffman, AS; Villar, CP; Kassem, RN; Flyer, DC; Andersen, BH; Kazempour, K; Breisch, SA; Glenn, GM (Jun 2008). "Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial". <i>Lancet</i>. 371 (9629): 2019–25. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2Fs0140-6736%2808%2960839-9">10.1016/s0140-6736(08)60839-9</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/18554712">18554712</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:32784525">32784525</a>.</li> <li>McKenzie, R; Bourgeois, AL; Frech, SA; Flyer, DC; Bloom, A; Kazempour, K; Glenn, GM (May 2007). "Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study". <i>Vaccine</i>. 25 (18): 3684–91. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2Fj.vaccine.2007.01.043">10.1016/j.vaccine.2007.01.043</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/17313998">17313998</a>.</li> <li>Glenn, GM; Villar, CP; Flyer, DC; Bourgeois, AL; McKenzie, R; Lavker, RM; Frech, SA (May 2007). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865773">"Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum"</a>. <i>Infect Immun</i>. 75 (5): 2163–70. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1128%2Fiai.01740-06">10.1128/iai.01740-06</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865773">1865773</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/17261601">17261601</a>.</li> <li>Glenn, GM; Thomas, DN; Poffenberger, KL; Flyer, DC; Ellingsworth, LR; Andersen, BH; Frech, SA (Dec 2009). "Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch". <i>Vaccine</i>. 27 (Suppl 6): G60–6. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2Fj.vaccine.2009.10.031">10.1016/j.vaccine.2009.10.031</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/20006142">20006142</a>.</li> <li>Kenney, RT; Frech, SA; Muenz, LR; Villar, CP; Glenn, GM (Nov 2004). <a href="https://doi.org/10.1056%2Fnejmoa043540">"Dose sparing with intradermal injection of influenza vaccine"</a>. <i>N Engl J Med</i>. 351 (22): 2295–301. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1056%2Fnejmoa043540">10.1056/nejmoa043540</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/15525714">15525714</a>.</li></ul>